Download PDF

Other users also viewed these articles

Faster-acting insulin aspart reduces glycaemic variability in sensor-augmented pump treated type 1 diabetes patients Jesus Moreno-Fernandez; Jose Alberto Garcia-Seco; Rita Virlaboa-Cebrian; Angela Maria Seco; Jose Ramon Muñoz-Rodriguez; Francisco Javier Gomez-Romero;
Endocrinol Diabetes Nutr. 2023;70:389-95
Executive summary. Screening, staging and follow-up of type 1 diabetes in preclinical stages: Consensus of the scientific societies SED, SEEN and SEEP María Asunción Martínez-Brocca; Virginia Bellido; Roque Cardona-Hernandez; Luis Castaño; Ignacio Conget; Alberto Fernández; Ana Lucía Gómez Gila; Isabel Leiva-Gea; Dídac Mauricio;
Endocrinol Diabetes Nutr. 2025;72:
Automated insulin delivery systems in the treatment of diabetes: Benefits, challenges, and practical considerations in pediatric patients Patricia Enes Romero; María Güemes; Blanca Guijo; Gabriel Á. Martos-Moreno; Jesús Pozo Román; Jesús Argente;
Endocrinol Diabetes Nutr. 2024;71:436-46